Literature DB >> 9482580

Molecular genetics of the long QT syndrome: two novel mutations of the KVLQT1 gene and phenotypic expression of the mutant gene in a large kindred.

K Saarinen1, H Swan, K Kainulainen, L Toivonen, M Viitasalo, K Kontula.   

Abstract

At least three different gene loci were recently shown to account for the long QT syndrome (LQTS), a monogenic disorder with altered myocardial repolarization and occurrence of life-threatening cardiac arrhythmias. We screened 44 unrelated probands for mutations of the gene encoding the cardiac potassium channel KVLQT1 using single-strand conformational polymorphism (SSCP) and subsequent DNA sequencing. Two different mutations, T182I and D188N, were identified in two separate pedigrees. Cosegregation of the mutation with the disease phenotype was evident in both families. No mutations were identified at codon 212, previously suggested to represent a mutational hot spot of the KVLQT1 channel, in any of the 44 probands. The large pedigree with the D188N mutation (30 affected and 43 nonaffected individuals) permitted an analysis of expression of the mutant gene in its documented carriers. Although the mean (+/-SD) QTc interval was markedly longer in affected (484+/-38 ms) than in nonaffected individuals (406+/-27 ms, P < 0.001), there was a marked overlapping of individual values in these two groups. QTc values in symptomatic and asymptomatic carriers of the mutant gene were not significantly different. In conclusion, we have identified two novel mutations of the KVLQT1 component of a cardiac potassium channel. Our data support the functional significance of the pore-S6 domain of this membrane protein and emphasize the diagnostic usefulness of DNA analyses in families with LQTS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9482580     DOI: 10.1002/(SICI)1098-1004(1998)11:2<158::AID-HUMU9>3.0.CO;2-F

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  8 in total

Review 1.  The significance of QT interval in drug development.

Authors:  Rashmi R Shah
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

Review 2.  Pharmacogenetics in drug regulation: promise, potential and pitfalls.

Authors:  Rashmi R Shah
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-08-29       Impact factor: 6.237

Review 3.  Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives.

Authors:  Rashmi R Shah
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

Review 4.  Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

5.  Functional significance of KCNH2 (HERG) K897T polymorphism for cardiac repolarization assessed by analysis of T-wave morphology.

Authors:  Eeva H Linna; Juha S Perkiömäki; Mari Karsikas; Tapio Seppänen; Markku Savolainen; Y Antero Kesäniemi; Timo Mäkikallio; Heikki V Huikuri
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-01       Impact factor: 1.468

6.  Cellular mechanisms of mutations in Kv7.1: auditory functions in Jervell and Lange-Nielsen syndrome vs. Romano-Ward syndrome.

Authors:  Atefeh Mousavi Nik; Somayeh Gharaie; Hyo Jeong Kim
Journal:  Front Cell Neurosci       Date:  2015-02-06       Impact factor: 5.505

7.  Tight coupling of rubidium conductance and inactivation in human KCNQ1 potassium channels.

Authors:  Guiscard Seebohm; Michael C Sanguinetti; Michael Pusch
Journal:  J Physiol       Date:  2003-10-15       Impact factor: 5.182

8.  Novel Roles for Kv7 Channels in Shaping Histamine-Induced Contractions and Bradykinin-Dependent Relaxations in Pig Coronary Arteries.

Authors:  Xingjuan Chen; Wennan Li; S Christopher Hiett; Alexander G Obukhov
Journal:  PLoS One       Date:  2016-02-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.